Production (Stage)
Sagimet Biosciences Inc.
SGMT
$3.55
$0.051.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 13.67% | -6.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.18% | 7.65% | |||
| Operating Income | -9.18% | -7.65% | |||
| Income Before Tax | -12.19% | -10.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.19% | -10.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.19% | -10.82% | |||
| EBIT | -9.18% | -7.65% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -12.20% | -10.64% | |||
| Normalized Basic EPS | -12.18% | -10.62% | |||
| EPS Diluted | -12.20% | -10.64% | |||
| Normalized Diluted EPS | -12.18% | -10.62% | |||
| Average Basic Shares Outstanding | 0.00% | 0.16% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||